PolyPeptide News Flash, #2, 2020
Business news
While the COVID-19 crisis continues, the PolyPeptide Group is actively engaged in helping find treatments and vaccines for COVID-19.
While the COVID-19 crisis continues, the PolyPeptide Group is actively engaged in helping find treatments and vaccines for COVID-19. See report on promising therapies in our latest Newsletter. We are also highlighting our ongoing Digitalization projects as well as introducing our new Global Director for Quality Control and Analytical Development, Eran Benjamin, read more
Related posts
27 August 2024